Wall Street brokerages forecast that Maximus, Inc. (NYSE:MMS) will announce $0.82 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Maximus’ earnings, with the highest EPS estimate coming in at $0.86 and the lowest estimate coming in at $0.77. Maximus reported earnings of $0.43 per share during the same quarter last year, which suggests a positive year over year growth rate of 90.7%. The firm is expected to report its next quarterly earnings results on Thursday, May 6th.
According to Zacks, analysts expect that Maximus will report full-year earnings of $3.68 per share for the current fiscal year, with EPS estimates ranging from $3.66 to $3.70. For the next financial year, analysts forecast that the business will post earnings of $4.30 per share, with EPS estimates ranging from $4.13 to $4.42. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that follow Maximus.
Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 4th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. Maximus had a return on equity of 17.60% and a net margin of 6.20%. The company had revenue of $945.60 million during the quarter, compared to analysts’ expectations of $846.46 million. During the same period in the prior year, the business earned $0.91 earnings per share. Maximus’s revenue for the quarter was up 15.6% compared to the same quarter last year.
In related news, Vice Chairman Richard A. Montoni sold 12,000 shares of the company’s stock in a transaction on Tuesday, December 8th. The stock was sold at an average price of $70.72, for a total value of $848,640.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 11,000 shares of the company’s stock in a transaction on Thursday, December 10th. The shares were sold at an average price of $71.27, for a total value of $783,970.00. The disclosure for this sale can be found here. Insiders sold 28,529 shares of company stock valued at $2,033,131 over the last 90 days. 2.00% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in MMS. Fieldpoint Private Securities LLC acquired a new position in Maximus during the fourth quarter worth $32,000. Point72 Hong Kong Ltd raised its stake in Maximus by 1,675.8% during the third quarter. Point72 Hong Kong Ltd now owns 586 shares of the health services provider’s stock worth $40,000 after acquiring an additional 553 shares in the last quarter. CI Investments Inc. acquired a new position in Maximus during the third quarter worth $43,000. JJJ Advisors Inc. raised its stake in Maximus by 372.9% during the fourth quarter. JJJ Advisors Inc. now owns 681 shares of the health services provider’s stock worth $50,000 after acquiring an additional 537 shares in the last quarter. Finally, Planned Solutions Inc. acquired a new position in Maximus during the fourth quarter worth $51,000. Hedge funds and other institutional investors own 92.89% of the company’s stock.
Shares of MMS traded up $0.18 during mid-day trading on Tuesday, hitting $83.31. The company’s stock had a trading volume of 7,413 shares, compared to its average volume of 383,444. Maximus has a one year low of $46.42 and a one year high of $84.73. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a market capitalization of $5.12 billion, a PE ratio of 24.45 and a beta of 0.84. The stock’s 50-day moving average is $78.59 and its two-hundred day moving average is $73.83.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 26th. Investors of record on Friday, February 12th will be paid a $0.28 dividend. The ex-dividend date is Thursday, February 11th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.34%. Maximus’s payout ratio is 33.04%.
Maximus, Inc provides business process services (BPS) to government health and human services programs worldwide. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.